{"id":14291,"date":"2018-09-20T13:35:10","date_gmt":"2018-09-20T11:35:10","guid":{"rendered":"https:\/\/news.embl.de\/?p=14291"},"modified":"2025-11-19T12:57:09","modified_gmt":"2025-11-19T11:57:09","slug":"promega-joins-embls-corporate-partnership-programme","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/","title":{"rendered":"Promega joins EMBL\u2019s Corporate Partnership Programme"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">By Julian Samojlow<\/h3>\n\n\n\n<p>EMBL warmly welcomes <a href=\"http:\/\/promega.de\/en\" target=\"_blank\" rel=\"noopener noreferrer\">Promega<\/a>, a global leader offering more than 4000 products in the fields of genomics,&nbsp;protein analysis and expression, cellular analysis, drug discovery and genetics, to the <a href=\"http:\/\/embl.de\/aboutus\/support-embl\/corporate-partnership-programme\" target=\"_blank\" rel=\"noopener noreferrer\">EMBL Advanced Training Centre Corporate Partnership Programme<\/a>.<\/p>\n\n\n\n<p>\u201cPromega and EMBL will collaborate to support young scientists interested in drug discovery and chemical biology,\u201d says Joe Lewis, Head of <a href=\"http:\/\/embl.de\/services\/core_facilities\/chemcore\" target=\"_blank\" rel=\"noopener noreferrer\">EMBL\u2019s Chemical Biology Core Facility<\/a>. \u201cIn the jointly organised course, \u2018<a href=\"http:\/\/embl.de\/training\/events\/2019\/TEG19-01\" target=\"_blank\" rel=\"noopener noreferrer\">Target Engagement in Biology and Drug Discovery<\/a>\u2019, we aim to give researchers hands-on practical experience and access to industry experts in the area of target engagement: how a small molecule interacts with its biological target in cells or in vitro, and how that plays a role in drug discovery.\u201d<\/p>\n\n\n\n<p>\u201cEMBL\u2019s International Centre for Advanced Training provides fantastic opportunities for young scientists to get access to high-level training courses and conferences,\u201d says Dr Peter Quick, General Manager of Promega Germany. \u201cWe\u2019re excited about this collaboration and are looking forward to contributing with Promega\u2019s luminescent technologies to different training courses, such as the upcoming target engagement and protein degradation workshop. EMBL\u2019s Corporate Partnership Programme encourages the close connection between scientists and industry which is essential for pushing science forward.\u201d<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">About the Corporate Partnership Programme<\/h4>\n\n\n\n<p>Founded in 2009, EMBL\u2019s Corporate Partnership Programme helps build mutually beneficial relationships between world-leading corporate partners and the academic community. In 2019, thanks to the generous support of&nbsp;Promega and&nbsp;<a href=\"http:\/\/embl.de\/aboutus\/support-embl\/corporate-partnership-programme\/current-partners\" target=\"_blank\" rel=\"noopener noreferrer\">current members of the programme<\/a>, more than 200 talented young scientists will receive financial assistance enabling them to contribute to and participate in courses and conferences at EMBL.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EMBL and Promega collaborate to train young scientists<\/p>\n","protected":false},"author":16,"featured_media":14294,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17595,3],"tags":[54,172,312,43,71,25,13072,27],"embl_taxonomy":[19535,5802],"class_list":["post-14291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-connections","category-lab-matters","tag-chemical-biology","tag-corporate-partnership-programme","tag-drug-discovery","tag-heidelberg","tag-industry","tag-partnerships","tag-support-embl","tag-training","embl_taxonomy-corporate-partnership-programme","embl_taxonomy-support-embl"],"acf":{"article_intro":"<p>EMBL and Promega collaborate to train young scientists<\/p>\n","related_links":[{"link_description":"","link_url":""},{"link_description":"","link_url":""}],"article_sources":false,"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"field_target_display":"embl","source_article":false,"in_this_article":false,"press_contact":"None","field_article_language":{"value":"english","label":"English"},"article_translations":false,"languages":"","vfwp-news_embl_taxonomy":[19535,5802]},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";i:2;s:36:\"0d3270ca-455c-428a-86f4-c61b1de8c3e0\";}","parents":[],"name":["Corporate Partnership Programme"],"slug":"corporate-partnership-programme","description":"What &gt; Support EMBL &gt; Corporate Partnership Programme"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What &gt; About EMBL &gt; Support EMBL"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL<\/title>\n<meta name=\"description\" content=\"Biotechnology company Promega joins EMBL&#039;s Corporate Partnership Programme, providing opportunities to support and train young scientists\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL\" \/>\n<meta property=\"og:description\" content=\"Biotechnology company Promega joins EMBL&#039;s Corporate Partnership Programme, providing opportunities to support and train young scientists\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-20T11:35:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-19T11:57:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Guest author(s)\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guest author(s)\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\"},\"author\":{\"name\":\"Guest author(s)\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\"},\"headline\":\"Promega joins EMBL\u2019s Corporate Partnership Programme\",\"datePublished\":\"2018-09-20T11:35:10+00:00\",\"dateModified\":\"2025-11-19T11:57:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg\",\"keywords\":[\"chemical biology\",\"corporate partnership programme\",\"drug discovery\",\"heidelberg\",\"industry\",\"partnerships\",\"support embl\",\"training\"],\"articleSection\":[\"Connections\",\"Lab Matters\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\",\"url\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\",\"name\":\"Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg\",\"datePublished\":\"2018-09-20T11:35:10+00:00\",\"dateModified\":\"2025-11-19T11:57:09+00:00\",\"description\":\"Biotechnology company Promega joins EMBL's Corporate Partnership Programme, providing opportunities to support and train young scientists\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg\",\"width\":620,\"height\":425,\"caption\":\"Promega logo\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b\",\"name\":\"Guest author(s)\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g\",\"caption\":\"Guest author(s)\"},\"description\":\"Guest author(s)\",\"url\":\"https:\/\/www.embl.org\/news\/author\/guest-author\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL","description":"Biotechnology company Promega joins EMBL's Corporate Partnership Programme, providing opportunities to support and train young scientists","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/","og_locale":"en_US","og_type":"article","og_title":"Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL","og_description":"Biotechnology company Promega joins EMBL's Corporate Partnership Programme, providing opportunities to support and train young scientists","og_url":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2018-09-20T11:35:10+00:00","article_modified_time":"2025-11-19T11:57:09+00:00","og_image":[{"width":620,"height":425,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","type":"image\/jpeg"}],"author":"Guest author(s)","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Guest author(s)","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/"},"author":{"name":"Guest author(s)","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b"},"headline":"Promega joins EMBL\u2019s Corporate Partnership Programme","datePublished":"2018-09-20T11:35:10+00:00","dateModified":"2025-11-19T11:57:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/"},"wordCount":272,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","keywords":["chemical biology","corporate partnership programme","drug discovery","heidelberg","industry","partnerships","support embl","training"],"articleSection":["Connections","Lab Matters"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/","url":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/","name":"Promega joins EMBL\u2019s Corporate Partnership Programme | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","datePublished":"2018-09-20T11:35:10+00:00","dateModified":"2025-11-19T11:57:09+00:00","description":"Biotechnology company Promega joins EMBL's Corporate Partnership Programme, providing opportunities to support and train young scientists","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/lab-matters\/promega-joins-embls-corporate-partnership-programme\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","width":620,"height":425,"caption":"Promega logo"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/b4d9366b2ebe691c4015c64c3619205b","name":"Guest author(s)","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/300b9a1d66050ae03eaeb99869c6ebb30f5184b9468e92a2b3e7d28bc9cf742d?s=96&d=mm&r=g","caption":"Guest author(s)"},"description":"Guest author(s)","url":"https:\/\/www.embl.org\/news\/author\/guest-author\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2018\/09\/Promega-Logo-for-web.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=14291"}],"version-history":[{"count":8,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14291\/revisions"}],"predecessor-version":[{"id":77307,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/14291\/revisions\/77307"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/14294"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=14291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=14291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=14291"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=14291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}